Common hospital stay
Often around 3-7 days when recovery is uncomplicated, but frailty, rhythm, vascular, kidney, or neurologic concerns can extend admission.
India cardiac treatment cost guide
Transcatheter aortic valve replacement, also called TAVI, treats selected patients with severe aortic stenosis without open-heart valve replacement. The final estimate depends heavily on the valve platform and size, CT anatomy, access route, coronary risk, anesthesia plan, rhythm risk, ICU use, and the hospital's ability to manage an urgent complication.
What does TAVR cost in India?
A practical 2026 planning range is about INR 18,00,000 to INR 38,00,000+ (approximately USD 18,700 to USD 39,500+) for the hospital episode. A straightforward transfemoral case may sit near the lower band; difficult access, high-risk anatomy, a premium or uncommon valve size, additional coronary work, a new pacemaker, or prolonged critical care can move the bill above it.
USD equivalents are rounded planning figures using about INR 96.22 per USD, based on the RBI reference display on July 15, 2026. Hospitals bill in INR; exchange rates, bank fees, and card charges can change the amount paid.
Share the basics and the Virello team will guide you toward the next step.
Prefer email? Write to support@virellohealth.com.
Reviewed 2026-07-18
Clinical review: Virello Health Clinical Review Team · Editorial review: Virello Health Medical Travel Editorial Team
Billing context: INR and USD
Often around 3-7 days when recovery is uncomplicated, but frailty, rhythm, vascular, kidney, or neurologic concerns can extend admission.
Allow time for Heart Team review, CT sizing, dental or infection clearance when requested, treatment, walking assessment, and a pre-flight review.
The named transcatheter valve and its procurement cost usually form the largest single part of the estimate.
TAVR should be compared with surgical valve replacement and, in selected cases, monitored care through a multidisciplinary Heart Valve Team.
Cost at a glance
The scenarios separate routine and complex pathways. They are not fixed packages and should be replaced by a report-led hospital estimate before travel.
| Scenario | INR | USD | Patient and treatment context | Planning scope |
|---|---|---|---|---|
| Standard transfemoral TAVR | INR 18,00,000-24,00,000 | USD 18,700-24,900 | Stable severe aortic stenosis, suitable femoral access, planned valve size, no simultaneous complex coronary procedure, and routine monitored recovery. | Valve, cath-lab or hybrid-theatre procedure, standard imaging and anesthesia, expected ICU or monitored bed, and routine admission assumptions must be confirmed. |
| Anatomically advanced pathway | INR 24,00,000-32,00,000 | USD 24,900-33,300 | Small annulus, difficult vascular access, bicuspid anatomy, prior valve, coronary protection concern, severe calcification, or greater anesthesia and monitoring needs. | May include advanced planning, specialized valve or protection devices, longer theatre time, and additional critical-care allowance. |
| Complex or complication pathway | INR 28,00,000-38,00,000+ | USD 29,100-39,500+ | Alternative access, valve-in-valve complexity, urgent conversion risk, vascular repair, stroke care, kidney injury, new pacemaker, or prolonged ICU stay. | Use as a reserve scenario rather than a fixed quote; rescue procedures, implants, blood, dialysis, rehabilitation, and excess days may be separate. |
Usually included
Interventional cardiology, cardiac surgery, valve imaging, anesthesia, and risk review used to confirm the proposed pathway.
Ask whether consultation and pre-admission testing are included.
The estimate should state manufacturer, model, size assumption, number of valves, and whether import or procurement changes the price.
Never accept a quote that says only “implant included.”
Hybrid theatre or cath lab, operator, anesthesia or sedation, standard wires and catheters, imaging, ICU or monitored bed, and ward stay within stated limits.
Day and room-category limits should be written.
Clinical review, ECG or telemetry, echo, access-site assessment, mobility check, prescriptions, valve card, and discharge summary.
Confirm whether the first outpatient review is included.
Confirm separately
Cerebral protection, coronary protection, lithotripsy, covered stents, closure devices beyond routine scope, or alternative-access equipment.
Ask what anatomy would trigger each item.
Coronary angioplasty, extra stents, balloon valvuloplasty, temporary or permanent pacemaker, mechanical support, or emergency surgery.
Request separate indicative prices before admission.
Vascular repair, stroke intervention, dialysis, prolonged ventilation, blood products, infection treatment, rehabilitation, or excess ICU days.
Understand daily overage and professional-fee rules.
Visa, flights, accommodation, attendant costs, home-country cardiology, repeat imaging, medicines, and future valve surveillance.
Keep these outside the hospital-package comparison.
Candidate context
Severe aortic stenosis is not priced from age alone. The Heart Valve Team considers symptoms, stenosis severity, life expectancy, surgical risk, frailty, anatomy, access, prior surgery, coronary disease, kidney function, patient goals, and the feasibility of future valve procedures before recommending TAVR.
Echo findings, symptoms, ventricular response, and sometimes catheter measurements establish whether intervention is appropriate now.
Annulus size, coronary height, calcium pattern, aorta, valve morphology, and iliofemoral vessels determine valve and access feasibility.
Frailty, cognition, mobility, kidney and lung health, prior stroke, bleeding, infection, and recovery goals matter alongside surgical scores.
Age, durability expectations, coronary access, future valve-in-valve options, and home follow-up should be discussed before implant selection.
SAVR may better suit some younger patients, anatomy needing aortic or coronary surgery, endocarditis, or situations where a durable surgical strategy is preferred.
Other valve lesions, aortic disease, or bypass needs can make an operation more appropriate than an isolated catheter procedure.
This may be used selectively as a bridge or for palliation, but it is not generally a durable replacement for definitive valve treatment.
When intervention is unlikely to improve survival or quality of life, the team may focus on symptoms and goals rather than an implant.
Procedure variations
Technique, device, medicine, treatment extent, and prior care can change both the clinical plan and the estimate.
Valve delivery through femoral arteries is the usual least-invasive route when vessels are suitable.
Access size, calcium, tortuosity, and prior grafts affect risk and device needs.
Axillary, carotid, transcaval, or other access may be considered when femoral delivery is unsuitable.
Availability, anesthesia, theatre time, and recovery can change the estimate.
A transcatheter valve may be placed within a failing surgical bioprosthesis in selected patients.
Old valve model, true internal diameter, gradients, and coronary obstruction risk are essential.
Uneven calcium, aortopathy, annular shape, or low coronary origins may require specialized planning or make surgery safer.
A generic standard-TAVR package is not enough.
City comparison
Only cities with evidence for the procedure should appear here. A city range does not prove that every hospital in that city can manage the same case complexity.
| City | Local range | USD range | Capability context | Stay planning |
|---|---|---|---|---|
| Delhi NCR and Gurugram | INR 19,00,000-38,00,000+ | USD 19,700-39,500+ | Broad access to structural-heart teams, advanced CT, surgery backup, and complex referral pathways. | Compare Delhi and Gurugram totals with accommodation and cross-city travel. |
| Mumbai | INR 20,00,000-38,00,000+ | USD 20,800-39,500+ | High-volume tertiary programs and multidisciplinary valve care are available at selected hospitals. | Budget carefully for nearby accessible lodging and attendant transport. |
| Bengaluru | INR 19,00,000-36,00,000+ | USD 19,700-37,400+ | Selected centers combine cardiac imaging, intervention, surgery, electrophysiology, and critical care. | Allow extra ground-travel time during peak traffic. |
| Chennai | INR 18,00,000-35,00,000+ | USD 18,700-36,400+ | Established cardiac surgery and catheter-valve teams serve complex domestic and international cases. | Choose lodging with easy access to the treating campus. |
| Hyderabad | INR 18,00,000-35,00,000+ | USD 18,700-36,400+ | Multiple tertiary cardiac programs can support imaging, cath lab, ICU, and surgical rescue. | Verify the named valve is stocked or can be procured before travel. |
| Kolkata | INR 18,00,000-34,00,000+ | USD 18,700-35,300+ | Selected referral hospitals offer structural-heart care for eastern India and nearby countries. | Confirm operator, valve platform, and emergency backup rather than choosing by city alone. |
| Ahmedabad | INR 18,00,000-34,00,000+ | USD 18,700-35,300+ | Selected tertiary centers offer advanced cardiac intervention with surgical support. | Check airport transfer, mobility access, and post-discharge review arrangements. |
| Pune | INR 18,00,000-34,00,000+ | USD 18,700-35,300+ | Some multispecialty cardiac centers provide catheter-valve planning and intensive care. | Ask whether all CT planning and valve sizing are completed on site. |
| Kochi | INR 18,00,000-33,00,000+ | USD 18,700-34,300+ | Selected cardiac referral programs support structural intervention and surgery. | Confirm language support, device availability, and the local recovery interval. |
| Indore or other value city | INR 18,00,000-32,00,000+ | USD 18,700-33,300+ | Appropriate stable cases may be considered only where a verified TAVR team, CT planning, valve inventory, ICU, and immediate surgery backup exist. | Lower lodging cost does not compensate for missing rescue capability. |
Estimate variables
Brand, generation, size, import status, procurement timing, and the possibility of a second valve can materially change cost.
Require the assumed product in writing.
Small, calcified, tortuous, diseased, or previously treated vessels can require alternative access or additional devices.
CT should be reviewed before quote comparison.
Low coronaries, severe leaflet calcium, prior stents, or concurrent disease may require protection, PCI, or a surgical alternative.
Ask whether PCI is staged or same-session.
Baseline bundle-branch block, valve depth, anatomy, and platform affect temporary monitoring and permanent pacemaker risk.
Pacemaker implantation is usually a separate charge.
Kidney disease, anemia, lung disease, mobility limits, or previous stroke can add specialist care and recovery time.
Travel readiness may lag behind technical success.
Hybrid theatre, vascular intervention, cardiac surgery, perfusion, blood bank, stroke response, and ICU depth add real safety value.
Compare capability before discount.
Medical cost breakdown
Confirms stenosis severity, ventricular function, other valves, pulmonary pressure, and baseline gradients.
TEE may be added for a specific question.
Measures annulus, valve, coronary origins, aorta, and access vessels for device sizing and risk planning.
Renal protection may be needed with impaired kidney function.
Angiography or CT review identifies disease requiring medicine, PCI, or surgical discussion.
Treatment of coronary disease may be a separate episode.
Blood tests, ECG, lung and kidney assessment, mobility, cognition, dental or infection status, and medication reconciliation.
Missing findings can delay admission.
The exact transcatheter heart valve, delivery catheter, and implant documentation.
Keep valve card and identifiers permanently.
Operators, anesthesia or sedation, imaging, standard access and closure, temporary pacing, and routine consumables.
Ask how advanced devices are billed.
Hemodynamic, neurologic, rhythm, vascular, kidney, and access-site observation after implantation.
Prolonged ICU usually attracts daily overage.
Echo, ECG, clinical and mobility review, medicines, warning signs, valve card, and follow-up plan.
Confirm whether rehabilitation input is included.
Symptoms, access site, rhythm, blood count, kidney function, ECG, and echo are checked as directed.
Timing varies by clinical course.
The cardiologist tailors antiplatelet or anticoagulant treatment to the valve, rhythm, bleeding, and coronary history.
Do not alter therapy for travel without approval.
Walking, nutrition, falls prevention, pulmonary exercises, and rehabilitation may be needed beyond wound healing.
Plan attendant support around function, not age.
Periodic cardiology and echocardiography monitor valve function, symptoms, rhythm, and future intervention needs.
Arrange home-country continuity before travel.
Complete journey budget
Patient and attendant costs should be modeled separately from the medical estimate, with flexible dates and a contingency reserve.
Patient and attendant tickets, wheelchair support, luggage, changes, and medical clearance documents.
Do not lock the return date before clinical review.
Official application fee, hospital letter, translations, scans, courier needs, and attendant documentation.
Use the Government of India portal.
Lift access, low-step bathroom, nearby food, transport, and proximity to the implanting hospital.
Frailty may make a cheaper distant hotel impractical.
Discharge medicines, laboratory work, ECG, echo, mobility support, and home cardiology review.
Confirm equivalents before returning home.
Extra stay, changed flights, vascular treatment, pacemaker, kidney care, stroke rehabilitation, or readmission.
Keep the reserve separate from the quoted package.
Country access
Visa, donor, fertility, medicine, licensing, and treatment-access requirements can change. Confirm current rules with the relevant authority and treating hospital.
Check nationality, medical and attendant categories, permitted stay, entries, documents, and current fees through the Government of India portal.
Carry the valve card, model and serial details, procedure report, final echo, discharge summary, medicines, and itemized invoice.
Ask who bears cost if the planned size changes, a valve is opened but not implanted, a second device is required, or treatment is cancelled after procurement.
Fainting, chest pain, severe breathlessness, low blood pressure, confusion, or acute deterioration requires urgent local assessment.
Hospital selection
Verify interventional, surgical, imaging, anesthesia, geriatric or frailty, rhythm, ICU, and rehabilitation input relevant to the case.
Ask who makes the final recommendation.
Discuss transfemoral, alternative access, bicuspid, small annulus, valve-in-valve, low coronary, and prior surgery experience as applicable.
Avoid unverified success-rate marketing.
Confirm image quality, sizing workflow, valve options, coronary strategy, access plan, and backup device availability.
Planning should precede a binding estimate.
Check hybrid room, cardiac surgery, perfusion, vascular intervention, stroke response, blood bank, and ICU readiness.
These capabilities should be on the same campus.
Request brand, size assumption, substitution consent, procurement deposit, refund terms, and second-valve billing.
Imported implants may have special terms.
Ask about telemetry duration, electrophysiology support, pacemaker price, early echo, travel clearance, and remote handover.
Conduction risk deserves a written plan.
Treating team
Reviews CT and valve anatomy, chooses access and implant strategy, and performs the catheter procedure.
Assesses surgical alternatives, lifetime strategy, and emergency conversion or combined-disease needs.
Integrates echo, CT, angiography, annular sizing, coronary risk, and post-implant valve performance.
Plans sedation or anesthesia, hemodynamics, airway, organ protection, and critical-care escalation.
Addresses conduction problems, pacing, mobility, frailty, medicine, and safe return-home planning.
Hospital comparison guides
Use these report-led guides to compare programme capability, clinical support, city fit, verification questions, recovery planning, and continuity after returning home.
Treatment timeline
The team verifies severe aortic stenosis, symptoms, previous procedures, organ health, frailty, and possible alternatives.
Annulus, coronaries, calcium, access, surgical risk, goals, and lifetime valve strategy are reviewed.
The hospital states valve model assumptions, access, room and day limits, advanced devices, pacemaker, and complication exclusions.
Examination, laboratory work, ECG, echo, CT quality, infection status, anesthesia, and consent are confirmed.
The valve is placed and the team watches hemodynamics, coronaries, rhythm, neurologic status, vessels, and kidneys.
Mobility, access site, medicines, echo, rhythm, warning signs, and travel timing are reviewed.
The local cardiologist continues clinical, echo, rhythm, medicine, rehabilitation, and implant-record follow-up.
Risks and edge cases
Access can cause bleeding, dissection, perforation, limb ischemia, or need for covered stent or surgery.
Small or calcified vessels increase planning complexity.
Embolic material can cause stroke, confusion, or a need for urgent imaging and rehabilitation.
Ask about stroke response and cerebral protection rationale.
The new valve can affect the conduction system, requiring longer monitoring or permanent pacing.
Obtain a separate pacemaker estimate.
Low coronaries, malposition, leak, embolization, annular injury, or poor function may need another valve, PCI, or surgery.
Backup strategy should be discussed before consent.
Contrast, hemodynamic stress, anesthesia, or baseline disease can prolong monitoring and recovery.
Share trends, dialysis status, and oxygen needs.
Frailty or another advanced illness may prevent meaningful improvement despite a technically successful implant.
Goals and expected benefit should be explicit.
Destination comparison
The most suitable destination depends on the individual case, required team, treatment availability, travel route, legal eligibility, budget, and continuity after returning home.
| Decision factor | India | Turkey | Thailand | How to use this |
|---|---|---|---|---|
| Typical planning range | Private-hospital pathways commonly require roughly USD 18,700-39,500+ depending on valve and complexity. | Quotes may be in EUR or USD and should identify the imported valve and room scope. | International programs often quote in THB or USD with varying hospitality and implant assumptions. | Compare the same valve model, access, ICU days, pacemaker, and rescue exclusions. |
| Structural-heart depth | Several metros combine CT, intervention, valve surgery, electrophysiology, vascular care, and ICU backup. | Advanced programs are concentrated in major referral centers. | Bangkok offers broad international structural-heart access, with narrower options elsewhere. | Match the hospital to anatomy, not only destination reputation. |
| Travel and recovery | Multiple gateways and city tiers offer choice, but a frail patient benefits from short ground travel and accessible lodging. | May offer shorter flights from Europe, the Middle East, and nearby regions. | International hospital services may simplify logistics for some Asian origins. | Count flight burden, mobility, local stay, and home follow-up. |
| Device transparency | The estimate should identify model, size assumption, import, second-valve, and cancellation terms. | Confirm currency and whether the valve is separately priced. | Ask whether a package includes the exact selected valve and advanced protection devices. | A destination total is not comparable without implant detail. |
Decision guidance
The patient is stable enough to travel, a complete CT and Heart Team review is available, the selected center has rescue depth, and home follow-up is arranged.
Alternative access, valve-in-valve, bicuspid anatomy, low coronaries, prior surgery, severe frailty, or possible pacemaker makes broad backup important.
The case is standard, the exact valve and experienced team are verified, and hybrid-room, surgery, vascular, rhythm, stroke, and ICU support are immediately available.
Symptoms are unstable, flight is unsafe, urgent intervention is required, or dependable post-implant echo, rhythm, medicine, and emergency follow-up cannot be secured.
Reports for review
Send the actual echo and TAVR-planning CT images when available, not only conclusions. Include prior valve and coronary records, symptom progression, frailty and mobility, kidney function, medicines, allergies, dental or infection concerns, and the patient's treatment goals so the Heart Team can judge both technical feasibility and likely benefit.
Upload medical reportsThese records determine severity, valve size, access, and procedural risk.
Include valve area, gradients, ventricular function, other valves, pulmonary pressure, and prior comparisons.
Provide DICOM images of annulus, coronaries, aorta, calcium, and access vessels with the formal report.
Share coronary images, prior stent cards, bypass notes, and any planned PCI discussion.
For valve-in-valve review, include operation note, valve card, model, size, year, and serial details.
These details help estimate benefit, monitoring, and local support.
Include CBC, creatinine and eGFR, liver profile, coagulation, glucose, electrolytes, and recent trends.
Provide bundle-branch block, atrial fibrillation, fainting, monitor reports, and existing device checks.
Describe walking distance, falls, daily activities, weight loss, cognition, oxygen, and attendant needs.
List antiplatelets, anticoagulants, allergies, bleeding, infection history, and what improvement matters to the patient.
Common questions
The terms are commonly used for the same transcatheter aortic valve treatment. TAVR emphasizes replacement and TAVI emphasizes implantation; the hospital should still identify the exact valve, access route, and plan.
It should state this clearly. Ask for manufacturer, model, size assumption, number of valves, import status, substitute consent, and who pays if a second valve or different size is required.
The imported transcatheter valve and delivery system form a large device cost. Surgery and TAVR have different recovery, risk, durability, and lifetime-strategy considerations, so price alone should not decide between them.
An uncomplicated pathway may involve several days, but rhythm changes, vascular injury, kidney issues, stroke concerns, frailty, or a pacemaker can extend admission. The team decides from recovery rather than a package promise.
Yes. The implant may affect cardiac conduction. Risk depends on baseline ECG, anatomy, valve platform and position, and the clinical course. Ask how monitoring and a permanent pacemaker would be billed.
No. Suitability depends on stenosis, symptoms, anatomy, expected benefit, surgical risk, frailty, other illness, life expectancy, and patient goals. Age is one part of a Heart Team decision.
Only selected centers with an experienced structural team, high-quality CT planning, the chosen valve, hybrid-room capability, immediate cardiac surgery and vascular rescue, stroke response, electrophysiology, and ICU support should be considered.
The team may discuss alternative access, vascular preparation, surgical replacement, or another plan. This can materially change risk, hospital choice, device needs, and cost.
The implanting team should confirm this after rhythm, access, kidney function, mobility, echo, medicines, and warning signs are stable. Frailty or a complication can delay safe air travel.
No. The treating Heart Valve Team recommends the intervention and device with the patient. Virello can coordinate records and itemized estimates but cannot make the clinical decision or guarantee price or outcome.
Review and sources
Virello reviewed recognized valve guidance, patient information, a current competitor benchmark, Indian market context, and RBI currency data. The range is split by transfemoral, anatomically advanced, and complication pathways because presenting one TAVR average would hide valve procurement, access, coronary, pacing, and rescue costs.
This guide is educational and does not diagnose aortic stenosis, determine TAVR eligibility, select a valve, or guarantee price or outcome. Fainting, chest pain, severe breathlessness, confusion, low blood pressure, or rapid deterioration requires urgent local medical assessment.
American Heart Association · Accessed 2026-07-18
Supports: Patient-facing TAVR description, catheter access, valve placement, recovery, and treatment discussion.
American College of Cardiology · Accessed 2026-07-18
Supports: Heart Valve Team review, severe aortic stenosis intervention, SAVR and TAVR decision context, and prosthesis strategy.
American Heart Association · Accessed 2026-07-18
Supports: Symptoms, valve-replacement options, hospital recovery, and continued cardiology follow-up.
MediJourney · Accessed 2026-07-18
Supports: Market range and hospital-stay benchmark used only as a competitor reference; Virello separates device and complexity assumptions.
Reserve Bank of India · Accessed 2026-07-18
Supports: INR and USD conversion context for rounded planning ranges.
Bureau of Immigration, Government of India · Accessed 2026-07-18
Supports: Medical and attendant visa categories and official application guidance.
Related planning
Compare completed country guides with the same device, admission, recovery, and travel questions.
Review candidate assessment, CT planning, valve implantation, risks, stay, and follow-up.
Compare surgical valve pathways, prosthesis choices, anticoagulation, and recovery.
Plan for permanent pacing if clinically required after a valve procedure.
Compare structural-heart imaging, intervention, surgery, rhythm, ICU, and rescue capability.
Understand how structural and coronary expertise differ when choosing a team.
Review surgical valve, aortic, redo, and emergency-backup experience.
Prepare echo, CT, angiography, laboratory, medicine, and prior valve records.
Ask for a valve-specific quote with access, day, pacemaker, and complication assumptions.
Arrange home cardiology, echo, rhythm, medicines, mobility, and emergency continuity.
Questions about an estimate? Email support@virellohealth.com.